GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » 3-Year EBITDA Growth Rate

Quantum Genomics (STU:2QG) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics 3-Year EBITDA Growth Rate?

Quantum Genomics's EBITDA per Share for the six months ended in Dec. 2022 was €-0.54.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Quantum Genomics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Quantum Genomics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum Genomics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum Genomics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Quantum Genomics's 3-Year EBITDA Growth Rate falls into.



Quantum Genomics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Quantum Genomics  (STU:2QG) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Quantum Genomics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (STU:2QG) Business Description

Traded in Other Exchanges
N/A
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines